Jak stosować TOBRAMIKINA OMNIVISION
Treść ulotki
Tobramicina OmniVision 0,3% eye drops, solution
tobramicina
Generic medicine
Read this leaflet carefully before you start to use this medicine because it contains important
information for you.
- Keep this leaflet. You may need to read it again.
- If you have any questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only. Do not pass it on to others, even if their symptoms are the same as yours, as it could be harmful.
- If you get any side effects, even those not listed in this leaflet, tell your doctor or pharmacist. See section 4.
Contents of this leaflet:
- 1. What Tobramicina OmniVision is and what it is used for
- 2. What you need to know before you use Tobramicina OmniVision
- 3. How to use Tobramicina OmniVision
- 4. Possible side effects
- 5. How to store Tobramicina OmniVision
- 6. Contents of the pack and other information
1. What is Tobramicina OmniVision and what is it used for
Tobramicina OmniVision contains the active ingredient tobramycin, an antibiotic from the
aminoglycoside family, which acts against various bacteria that can cause eye infections.
This medicine is used in adults and children from two years of age to treat infections
of the eye and related structures, caused by bacteria sensitive to tobramycin:
acute, sub-acute and chronic catarrhal inflammations of the conjunctiva (the transparent membrane that lines the
white part of the eye and the inside of the eyelids); inflammation of the eyelid; inflammation of the
cornea (the transparent membrane that covers the colored part of the eye); inflammation of the lacrimal sac.
Tobramicina OmniVision is also used before and after surgical procedures on the front part of the eye.
2. What you need to know before using Tobramicina OmniVision
Do not use Tobramicina OmniVision
if you are allergic to tobramycin or any of the other ingredients of this medicine (listed in
section 6).
Warnings and precautions
Talk to your doctor or pharmacist before using Tobramicina OmniVision.
In some patients, sensitization (allergic reaction) to aminoglycoside antibiotics
such as tobramycin, administered to the eyes, may occur. This allergic reaction may range from itching or
redness of the skin localized, to severe general allergic reactions (anaphylactic reactions) or severe
skin reactions. If these symptoms occur during the use of Tobramicina OmniVision, stop
treatment and see your doctor. Also, keep in mind that this allergic sensitivity may occur
even with other antibiotics belonging to the same class of aminoglycosides, administered both to the eyes
and systemically (by injection).
Talk to your doctor if you have or have ever had conditions such as myasthenia gravis or Parkinson's disease. Antibiotics
of this type can worsen muscle weakness.
In patients who have taken tobramycin systemically (by injection), serious adverse effects
on the nervous system, ears and kidneys have occurred. Be careful and see your doctor
if you are using Tobramicina OmniVision together with tobramycin taken systemically (by injection).
As with other antibiotics, if you use Tobramicina OmniVision for a long time, you may
become more susceptible to eye infections, even those caused by fungi. If your symptoms
worsen or reappear suddenly, see your doctor.
Do not wear contact lenses during the treatment of an eye infection (see also the section
“Tobramicina OmniVision 0.3% eye drops, solution contains benzalkonium chloride”).
Other medicines and Tobramicina OmniVision
Tell your doctor or pharmacist if you are taking, have recently taken or might take any
other medicines.
Incompatibilities
The tyloxapol component is incompatible with tetracycline. Do not use Tobramicina OmniVision together
with other eye products containing tetracycline.
Tobramicina OmniVision with food and alcohol
Not applicable.
Pregnancy, breastfeeding and fertility
If you are pregnant, suspect you are pregnant or are planning a pregnancy, or if you are breastfeeding with breast
milk, ask your doctor or pharmacist for advice before using this medicine.
Pregnancy
Data relating to the application of tobramycin to the eyes in pregnant women are unavailable or are
limited. Studies in animals have shown reproductive toxicity. Tobramycin should
be used during pregnancy only if strictly necessary.
Breastfeeding
It is not known whether tobramycin is excreted in breast milk after application to the eyes. Tobramycin is
excreted in breast milk after systemic administration (by injection). The risk to infants cannot
be excluded. Ask your doctor, who will decide whether you should stop breastfeeding or
stop therapy with tobramycin.
Fertility
No studies have been conducted to evaluate the effect on human fertility of topical
ocular administration of Tobramicina OmniVision.
Driving and operating machinery
Tobramicina OmniVision does not alter or transiently alters the ability to drive vehicles and operate
machinery.
For a certain period of time after instillation of Tobramicina OmniVision, blurred vision or other visual disturbances may occur that can affect the ability to drive vehicles and
operate machinery. If these effects occur, wait for your vision to clear before driving
vehicles and operating machinery
Tobramicina OmniVision contains benzalkonium chloride
This medicine contains 2.95 micrograms of benzalkonium chloride per drop equivalent to 0.1 mg/ml.
Benzalkonium chloride can be absorbed by soft contact lenses and can lead to a change in
their color. Remove contact lenses before using this medicine and wait 15 minutes before
reapplying them.
Benzalkonium chloride can also cause eye irritation, especially if you have dry eyes or corneal disorders (the most superficial transparent layer of the eye). If you experience an abnormal sensation in your eye, burning or pain after using this medicine, talk to your doctor.
Tobramicina OmniVision contains boric acid
This medicine should not be administered to children under 2 years of age, as it contains
boron and may damage fertility in the future.
3. How to use Tobramicina OmniVision
Use this medicine following the instructions of your doctor or pharmacist exactly. If you have any doubts
consult your doctor or pharmacist.
The recommended dose is: two drops, four times a day in acute forms, and three times a day in
chronic forms, as prescribed by your doctor. Use the product for the period of time specified by your
doctor.
Instill into the eye.
The following operation is useful to limit the amount of medicine that passes into the blood after
application to the eyes:
- keep the eyelid closed and apply gentle pressure with a finger on the inner corner of the eye near the nose for at least 2 minutes. If you are using other eye drops or ophthalmic ointments, allow at least 5 minutes to pass between the instillation of each medicine. The ophthalmic ointment should be used last.
Use in children and adolescents
Do not use Tobramicina Omnivision in children under two years of age as safety and efficacy have not been established in this
population and no data are available.
Tobramicina Omnivision can be used in children aged two years and over at the same doses as
for adults.
If you use more Tobramicina OmniVision than you should
If you use more medicine than you should, immediately wash your eye with lukewarm water. However, no adverse
effects are expected.
Do not use the medicine again until the time scheduled for the next administration.
If you forget to use Tobramicina OmniVision
If you forget to use Tobramicina OmniVision, do not worry and instill it as soon as you remember. However,
if it is almost time to administer the next dose, skip the forgotten dose and return to the regular schedule of
administration.
Do not use a double dose to make up for a missed dose.
If you have any doubts about the use of this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
With the use of Tobramicina OmniVision, the following side effects have been reported.
Common side effects (may affect up to 1 in 10 people)
- Effects on the eyes: eye discomfort, redness. Uncommon side effects (may affect up to 1 in 100 people)
- Effects on the eyes: inflammation of the eye surface, damage to the cornea (the transparent membrane covering the colored part of the eye), impaired vision, blurred vision, redness of the eyelids, swelling of the eye and eyelid, eye pain, dry eye, eye secretion, eye itching, increased tearing.
- General side effects: allergy (hypersensitivity), headache, urticaria, skin inflammation (dermatitis), decreased growth or number of eyelashes, loss of skin color, itching, dry skin.
Side effects of unknown frequency (frequency cannot be estimated based on available data
)
- Effects on the eyes: ocular allergy, eye irritation, eyelid itching.
- General side effects: severe allergic reactions, skin rash, severe skin rashes (Stevens-Johnson syndrome, erythema multiforme).
Reporting of side effects
If you get any side effects, even those not listed in this leaflet, tell your
doctor or pharmacist. You can also report side effects directly through the national reporting system at .
By reporting side effects you can help provide more information on the safety of this
medicine.
5. How to store Tobramicina OmniVision
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the label and the packaging after “Exp.”.
The expiry date refers to the last day of that month.
Do not store at a temperature above 25°C.
The product must not be used for more than 30 days after first opening the container.
Do not dispose of any medicine in waste water or household waste. Ask your pharmacist how to dispose of
medicines you no longer use. This will help protect the environment.
6. Contents of the pack and other information
What Tobramicina OmniVision contains
- The active substance is tobramycin. 1ml of eye drops contains 3 mg of tobramycin.
- The other ingredients are: tyloxapol, boric acid, anhydrous sodium sulfate, sodium chloride, benzalkonium chloride, purified water.
Description of the appearance of Tobramicina OmniVision and contents of the pack
5 ml bottle, in low-density neutral polyethylene, with dropper, sealed with a cap in
polypropylene.
Marketing Authorisation Holder
OmniVision Italia S.r.l.
Via Montefeltro, 6
20156 Milano, Italy
Manufacturer
Bruschettini S.r.l.
Via Isonzo, 6
16147 Genova, Italy

- Kraj rejestracji
- Postać farmaceutycznaEye drops, solution, 0.3%
- Kod ATCS01AA12
- Substancja czynna
- Wymaga receptyTak
- Producent
- Te treści mają charakter wyłącznie informacyjny i nie zastępują konsultacji lekarskiej.
- Zamienniki TOBRAMIKINA OMNIVISIONPostać farmaceutyczna: Eye drops, solution, 0.3%Substancja czynna: tobramycinProducent: DIADEMA FARMACEUTICI SRLWymaga receptyPostać farmaceutyczna: Eye drops, solution, 0.3%Substancja czynna: tobramycinProducent: D.M.G. ITALIA S.R.L.Wymaga receptyPostać farmaceutyczna: Eye drops, solution, 0.3%Substancja czynna: tobramycinProducent: NOVARTIS FARMA S.P.A.Wymaga recepty
Odpowiedniki TOBRAMIKINA OMNIVISION w innych krajach
Leki z tą samą substancją czynną dostępne w innych krajach.
Odpowiednik TOBRAMIKINA OMNIVISION w Polska
Odpowiednik TOBRAMIKINA OMNIVISION w Ukraina
Odpowiednik TOBRAMIKINA OMNIVISION w Hiszpania
Lekarze online w sprawie TOBRAMIKINA OMNIVISION
Omów stosowanie TOBRAMIKINA OMNIVISION, bezpieczeństwo i ocenę zasadności recepty zgodnie z obowiązującymi przepisami.
Uzyskaj receptę na TOBRAMIKINA OMNIVISION online
Wypełnij 2-minutowy formularz
Opisz swoje objawy, historię choroby i lek, o który prosisz.
Wybierz lekarza lub pozwól nam przydzielić
Wybierz specjalistę lub dopasujemy Cię do najbliższego dostępnego lekarza.
Lekarz analizuje Twój przypadek
Zazwyczaj w ciągu 30 minut. Może zadawać dodatkowe pytania przez czat.
Odbierz w dowolnej aptece
Recepta elektroniczna wysłana na Twój e-mail — ważna w całej Polsce.
Często zadawane pytania
TOBRAMIKINA OMNIVISION wymaga recepty w Włochy. Możesz skonsultować się z lekarzem online, aby sprawdzić, czy ten lek może być odpowiedni w Twojej sytuacji.
Substancją czynną w TOBRAMIKINA OMNIVISION jest tobramycin. Informacja ta pomaga rozpoznać leki o tym samym składzie, ale pod różnymi nazwami handlowymi.
TOBRAMIKINA OMNIVISION jest produkowany przez OMNIVISION ITALIA SRL. Nazwy handlowe i opakowania mogą się różnić w zależności od dystrybutora.
Lekarze, tacy jak Lekarze rodzinni, Psychiatrzy, Dermatolodzy, Kardiolodzy, Endokrynolodzy, Gastroenterolodzy, Pulmonolodzy, Nefrolodzy, Reumatolodzy, Hematolodzy, Zakaźnicy, Alergolodzy, Geriatrzy, Pediatrzy, Onkolodzy, mogą ocenić, czy stosowanie TOBRAMIKINA OMNIVISION jest odpowiednie w Twoim przypadku, w zależności od sytuacji klinicznej i lokalnych przepisów. Możesz umówić konsultację online, aby omówić objawy i możliwe dalsze kroki.
Polska posiada dobrze rozwiniętą infrastrukturę ochrony zdrowia w dużych miastach, takich jak Warszawa, Kraków, Wrocław i Gdańsk. Apteki są łatwo dostępne i działają zgodnie z obowiązującymi przepisami, zapewniając dostęp do leków na receptę.
Możesz kupić TOBRAMIKINA OMNIVISION w Warszawie, Krakowie, Wrocławiu lub Gdańsku w każdej aptece, posiadając ważną receptę.
Aby uzyskać receptę, możesz skorzystać z Oladoctor:
Inne leki zawierające tę samą substancję czynną (tobramycin) to m.in. OKUPIX, PAIDOMIKINA, TOBRAL. Mogą one różnić się nazwą handlową lub postacią, ale zawierają ten sam składnik terapeutyczny. Przed zmianą lub rozpoczęciem nowego leku skonsultuj się z lekarzem.
















